Answers are grounded in this paper and cite their sources.
The emergence of revised definitions for the high-risk patient with cutaneous malignant melanoma prompts us to re-examine the current status of adjuvant therapy in this disease. We wish to address the question, "once a cutaneous melanoma is surgically removed and the patient is currently free of disease but at high risk for metastases, what can be done to prevent recurrence"?
No takes yet. Share an insight, caveat, or question.
Koh et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: